|
1
|
Vindrieux D, Escobar P and Lazennec G:
Emerging roles of chemokines in prostate cancer. Endocr Relat
Cancer. 16:663–673. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Slettenaar VI and Wilson JL: The chemokine
network: a target in cancer biology? Adv Drug Deliv Rev.
58:962–974. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar
|
|
4
|
Ben-Baruch A: The multifaceted roles of
chemokines in malignancy. Cancer Metastasis Rev. 25:357–371. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Keeley EC, Mehrad B and Strieter RM: CXC
chemokines in cancer angiogenesis and metastases. Adv Cancer Res.
106:91–111. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Müller A, Homey B, Soto H, et al:
Involvement of chemokine receptors in breast cancer metastasis.
Nature. 410:50–56. 2001.PubMed/NCBI
|
|
7
|
Rubie C, Frick VO, Ghadjar P, et al: CXC
receptor-4 mRNA silencing abrogates CXCL12-induced migration of
colorectal cancer cells. J Transl Med. 9:222011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liang JJ, Zhu S, Bruggeman R, et al: High
levels of expression of human stromal cell-derived factor-1 are
associated with worse prognosis in patients with stage II
pancreatic ductal adenocarcinoma. Cancer Epidemiol Biomarkers Prev.
19:2598–2604. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Castellone MD, Guarino V, De Falco V, et
al: Functional expression of the CXCR4 chemokine receptor is
induced by RET/PTC oncogenes and is a common event in human
papillary thyroid carcinomas. Oncogene. 23:5958–5967. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Phillips RJ, Burdick MD, Lutz M, Belperio
JA, Keane MP and Strieter RM: The stromal derived
factor-1/CXCL12-CXC chemokine receptor 4 biological axis in
non-small cell lung cancer metastases. Am J Respir Crit Care Med.
167:1676–1686. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kang H, Watkins G, Parr C, Douglas-Jones
A, Mansel RE and Jiang WG: Stromal cell derived factor-1: its
influence on invasiveness and migration of breast cancer cells in
vitro, and its association with prognosis and survival in human
breast cancer. Breast Cancer Res. 7:R402–410. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wendt MK, Cooper AN and Dwinell MB:
Epigenetic silencing of CXCL12 increases the metastatic potential
of mammary carcinoma cells. Oncogene. 27:1461–1471. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar
|
|
14
|
Ii M, Yamamoto H, Adachi Y, Maruyama Y and
Shinomura Y: Role of matrix metalloproteinase-7 (matrilysin) in
human cancer invasion, apoptosis, growth, and angiogenesis. Exp
Biol Med (Maywood). 231:20–27. 2006.PubMed/NCBI
|
|
15
|
Tang CH, Tan TW, Fu WM and Yang RS:
Involvement of matrix metalloproteinase-9 in stromal cell-derived
factor-1/CXCR4 pathway of lung cancer metastasis. Carcinogenesis.
29:35–43. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chakrabarti S and Patel KD: Matrix
metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology. Exp
Lung Res. 31:599–621. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Iijima T, Minami Y, Nakamura N, et al:
MMP-2 activation and stepwise progression of pulmonary
adenocarcinoma: analysis of MMP-2 and MMP-9 with gelatin
zymography. Pathol Int. 54:295–301. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Okada N, Ishida H, Murata N, Hashimoto D,
Seyama Y and Kubota S: Matrix metalloproteinase-2 and -9 in bile as
a marker of liver metastasis in colorectal cancer. Biochem Biophys
Res Commun. 288:212–216. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rao JS, Gondi C, Chetty C, Chittivelu S,
Joseph PA and Lakka SS: Inhibition of invasion, angiogenesis, tumor
growth, and metastasis by adenovirus-mediated transfer of antisense
uPAR and MMP-9 in non-small cell lung cancer cells. Mol Cancer
Ther. 4:1399–1408. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Su L, Zhang J, Xu H, et al: Differential
expression of CXCR4 is associated with the metastatic potential of
human non-small cell lung cancer cells. Clin Cancer Res.
11:8273–8280. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jemal A, Murray T, Ward E, et al: Cancer
statistics, 2005. CA Cancer J Clin. 55:10–30. 2005. View Article : Google Scholar
|
|
22
|
Talmadge JE and Fidler IJ: AACR centennial
series: the biology of cancer metastasis: historical perspective.
Cancer Res. 70:5649–5669. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fidler IJ: The pathogenesis of cancer
metastasis: the ‘seed and soil’ hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003.
|
|
24
|
Geiger TR and Peeper DS: Metastasis
mechanisms. Biochim Biophys Acta. 1796:293–308. 2009.PubMed/NCBI
|
|
25
|
Hynes RO: Metastatic potential: generic
predisposition of the primary tumor or rare, metastatic variants-or
both? Cell. 113:821–823. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liotta LA: An attractive force in
metastasis. Nature. 410:24–25. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liang Z, Yoon Y, Votaw J, Goodman MM,
Williams L and Shim H: Silencing of CXCR4 blocks breast cancer
metastasis. Cancer Res. 65:967–971. 2005.PubMed/NCBI
|
|
28
|
do Carmo A, Patricio I, Cruz MT,
Carvalheiro H, Oliveira CR and Lopes MC: CXCL12/CXCR4 promotes
motility and proliferation of glioma cells. Cancer Biol Ther.
9:56–65. 2010.
|
|
29
|
Zlotnik A: Involvement of chemokine
receptors in organ-specific metastasis. Contrib Microbiol.
13:191–199. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wagner PL, Hyjek E, Vazquez MF, et al:
CXCL12 and CXCR4 in adenocarcinoma of the lung: association with
metastasis and survival. J Thorac Cardiovasc Surg. 137:615–621.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Uchida D, Onoue T, Tomizuka Y, et al:
Involvement of an autocrine stromal cell derived factor-1/CXCR4
system on the distant metastasis of human oral squamous cell
carcinoma. Mol Cancer Res. 5:685–694. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wendt MK, Johanesen PA, Kang-Decker N,
Binion DG, Shah V and Dwinell MB: Silencing of epithelial CXCL12
expression by DNA hypermethylation promotes colonic carcinoma
metastasis. Oncogene. 25:4986–4997. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Staller P, Sulitkova J, Lisztwan J, Moch
H, Oakeley EJ and Krek W: Chemokine receptor CXCR4 downregulated by
von Hippel-Lindau tumour suppressor pVHL. Nature. 425:307–311.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hsu CP, Shen GH and Ko JL: Matrix
metalloproteinase-13 expression is associated with bone marrow
microinvolvement and prognosis in non-small cell lung cancer. Lung
Cancer. 52:349–357. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Gangadhar T, Nandi S and Salgia R: The
role of chemokine receptor CXCR4 in lung cancer. Cancer Biol Ther.
9:409–416. 2010. View Article : Google Scholar : PubMed/NCBI
|
